Visceral Leishmaniasis (VL) Clinical Presentation, Laboratory Findings, Treatment Options and Outcome
Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas. This study was a ret...
Saved in:
Published in | Iranian journal of parasitology Vol. 19; no. 1; pp. 28 - 37 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Iran
Tehran University of Medical Sciences
01.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various
species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas.
This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled.
Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were.
VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration. |
---|---|
AbstractList | Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas.
Methods: This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled.
Results: Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were.
Conclusion: VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration. Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas. This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled. Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were. VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration. Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas. Methods: This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled. Results: Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were. Conclusion: VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration. BackgroundBlack disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas.MethodsThis study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled.ResultsTwenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were.ConclusionVL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration. |
Author | Moradian, Elham Sarvari, Maedeh Khodabandeh, Mahmoud Khiabani, Mahsa Soti |
Author_xml | – sequence: 1 givenname: Mahmoud surname: Khodabandeh fullname: Khodabandeh, Mahmoud organization: Department of Pediatrics, Children's Medical Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran – sequence: 2 givenname: Elham surname: Moradian fullname: Moradian, Elham organization: Children's Medical Center, Pediatrics Center of Excellence, Tehran, Iran – sequence: 3 givenname: Maedeh surname: Sarvari fullname: Sarvari, Maedeh organization: School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran – sequence: 4 givenname: Mahsa Soti surname: Khiabani fullname: Khiabani, Mahsa Soti organization: Department of Pediatrics, Children's Medical Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38654944$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU9rGzEQxUVJadw0H6CXsscUsq60-rPyqQTTpAGDe0hDb2J2d-TI7EqutA7k21drJ6HRRaB58xu9eR_JiQ8eCfnM6JxpSatvbruD-SNbODZnki3oOzKrKNVlxfWfEzJjNZdlTSt6Ss5T2tJ8eKWVUh_IKddKioUQM4L3LrUYoS9W6NLDAN5Bcqm4uF99LZa9867NtV8RE_oRRhf8ZbGCJkQYQ3wqrp3vnN-ky-IuIoxDFhXr3SRLBfiuWO_HNgz4iby30Cc8f77PyO_rH3fLn-VqfXO7vFqVrWB6LFmHQqt6ISjKiitrW6RMZyPQtVI0ja5AQPbYCCaxYZ3SQoi6y95ZUwvW8TNye-R2AbZmF90A8ckEcObwEOLGQBxd26PRAixiPTG4kByBWYu26pqqsVbCxPp-ZO32zYBdm63lNb2Bvq1492A24dEwRjmXXGXCxTMhhr97TKMZpmX3PXgM-2Q4FUoyXimRpewobWNIKaJ9ncOoOcRtprjNIW5ziDv3fPn_g68dL-Hyf7leqrI |
ContentType | Journal Article |
Copyright | Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences. Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences 2024 |
Copyright_xml | – notice: Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences. – notice: Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences 2024 |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.18502/ijpa.v19i1.15190 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2008-238X |
EndPage | 37 |
ExternalDocumentID | oai_doaj_org_article_84afee7d6843453ea1ffef2db2bff5ad 10_18502_ijpa_v19i1_15190 38654944 |
Genre | Journal Article |
GroupedDBID | --- 2NT 2WC 3V. 53G 5GY 5VS 7X7 8C1 8FI 8FJ 8R4 8R5 ABDBF ABUWG ADBBV ADRAZ AENEX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CWDGH DIK EBD ECGQY EOJEC ESX FYUFA GROUPED_DOAJ HMCUK HYE IPNFZ KQ8 M48 M~E NPM OBODZ OK1 PGMZT PIMPY PQQKQ PROAC Q2X RIG RNS RPM TR2 TUS UKHRP ~8M AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c418t-1de4867940e5236ffce018173adc54bb82a4a200b415eb1d684447d1901b741d3 |
IEDL.DBID | RPM |
ISSN | 1735-7020 |
IngestDate | Tue Oct 22 15:16:01 EDT 2024 Tue Sep 17 21:28:21 EDT 2024 Sat Aug 17 05:18:52 EDT 2024 Fri Aug 23 03:06:05 EDT 2024 Sat Nov 02 11:54:08 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Treatment Children Diagnosis Iran Visceral leishmaniasis Epidemiology |
Language | English |
License | Copyright©2024 Khodabandeh et al. Published by Tehran University of Medical Sciences. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c418t-1de4867940e5236ffce018173adc54bb82a4a200b415eb1d684447d1901b741d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11033536/ |
PMID | 38654944 |
PQID | 3046513264 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_84afee7d6843453ea1ffef2db2bff5ad pubmedcentral_primary_oai_pubmedcentral_nih_gov_11033536 proquest_miscellaneous_3046513264 crossref_primary_10_18502_ijpa_v19i1_15190 pubmed_primary_38654944 |
PublicationCentury | 2000 |
PublicationDate | 2024-01-01 |
PublicationDateYYYYMMDD | 2024-01-01 |
PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Iran |
PublicationPlace_xml | – name: Iran |
PublicationTitle | Iranian journal of parasitology |
PublicationTitleAlternate | Iran J Parasitol |
PublicationYear | 2024 |
Publisher | Tehran University of Medical Sciences |
Publisher_xml | – name: Tehran University of Medical Sciences |
SSID | ssj0000328666 |
Score | 2.3303537 |
Snippet | Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various
species. The risk of morbidity and mortality increases with... Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and... BackgroundBlack disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 28 |
SubjectTerms | Children Diagnosis Epidemiology Iran Original Treatment Visceral leishmaniasis |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUQh4oLKhToQqlciQNUBBLHzjrHFnWF0PJxAMTN8qc2CLKI7Fbqv--Mk4VdVKkXrnGiWG9GM2_s8TMhe5l1orRcJ6hNl3DNbFJabHaAVC-dcYKleDj5_KI4veFnd-Ju7qov7Alr5YFb4I4l18H7viskz7nIvc5C8IE5w0wIQrsYfdNyrpiKMThnsogblVkfNRmBFHVbmlKk7Li6f9JHv7Oyyo4g42E8nktKUbv_X4Tzbd_kXCIafCSrHYOkP9qZr5ElX6-TD-fdHvkn4m-rxuJKEx36qhmhvoVuqobu3w4PaCcD-kCvXo8d1Yd02LrC-PkPHVTxnEtzSK9nPej0su18obp29HI6ASf1G-Rm8Ov65DTpLlNILM_kJMmcj-J6PPVQexYhWI9aXf1cOyu4MZJpsFSaGsjoEL8Rb877DvmCAdbh8k2yXI9r_5nQAoKkzYSTaWk4GAc-Lo0BqiFd6lhgPfJ9hqZ6ajUzFNYaCL1C6FWEXkXoe-Qn4v3yIspdxwfgBKpzAvU_J-iRbzNrqUcE-QE7hcfTRuHGr4CKu-A9stVa7-VXeN0pLzmMyAW7LsxlcaSuRlGCG0hTnou82H6P2e-QFQZUqV3Y-UKWJ89TvwtUZ2K-Rq_-C6uE_ok priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LTxsxELYQlbhVfdA2fcmVOLSITXe99sZ7qKq2IkJVgB4I4mb5WRaFDc0mFfx7Zrwb2qAckPa0L1vjsecbz_gbQnYy60RpuU6Qmy7hmtmktJjsAKZeOuMES_Fw8uFRcTDmP8_E2QZZlrfqBNisde2wntR4Nulf_7n5ChP-C054KVL2ubq40v2_WVllfTBgJXjwjxgHRx0z-Tq0HxfmnMkiRi-zARI1AlLq4pxr_7JiqSKh_zoUej-Z8j_rNHxCHnewkn5r9eAp2fD1M7J12AXOnxN_WjUWt5_oyFfNOZJe6KZq6MfT0SfacYNO6K9_Z5HqPTpq9WM6u6HDKh5-afboyTIxnR636TBU144eL-aguX6bjIf7Jz8Okq7CQmJ5JudJ5nxk3OOpB4e0CMF6JPAa5NpZwY2RTMPwpakBMw-Luisk53zgEEQYgCIuf0E262ntXxFawMppM-FkWhoevIePS2MAf0iXOhZYj-wupamuWiINhQ4Iil6h6FUUvYqi75HvKO-7F5EDO96Yzn6rbkopyTW0M8BO5VzkXmch-MCcYSYEoV2PfFiOlrpEIU8wfXi6aBRGgwW44QXvkZft6N01hTVQecnhiVwZ15W-rD6pq_PIyw1IKs9FXrx-QMNvcIMg7uTA9ZZszmcL_w7gzdy8j0p7C5w8-ag priority: 102 providerName: Scholars Portal |
Title | Visceral Leishmaniasis (VL) Clinical Presentation, Laboratory Findings, Treatment Options and Outcome |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38654944 https://search.proquest.com/docview/3046513264 https://pubmed.ncbi.nlm.nih.gov/PMC11033536 https://doaj.org/article/84afee7d6843453ea1ffef2db2bff5ad |
Volume | 19 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe2ISFeEN90g8pIPABa2tixE-eRlZUKtVuFttG3yF9hQW1aNS0S_z1nJxkt4omXRIpj2bo73Yfv7meE3hJteKqZDBw2XcAk1UGqXbEDmHphlOE0dM3Jk4t4dM2-zPjsAMVtL4wv2teq6JXzRa8sbn1t5Wqh-22dWH86GYDJiiIexf1DdAgSuhOje_0bURH7JCVJHB4jOERNOlPwkPaLHyvZ-0nSgvTA2jldvGOQPG7_v5zNv2smd4zQ8BF62HiP-GO9y8fowJZP0P1Jkx9_iuxNUWl3yoTHtqhuHbaFrIoKv7sZv8cNBOgcT_-0HJWneFyLwXL9Cw8L3-NSneKrtv4cX9ZVL1iWBl9uNyCg9hm6Hp5fDUZBc5FCoBkRm4AY64H1WGgh7ozzXFuH05VE0mjOlBJUApfCUIE1B91tYsEYS4zzFRR4HCZ6jo7KZWlfIhyDgtSEGxGmiuXWwuRUKXAzhAkNzWkHfWipma1qvIzMxRmO9JkjfeZJn3nSd9CZo_fdjw7q2n9Yrr9nDcMzwSSsk7hNRYxHVpI8tzk1iqo859J00JuWW9nCEXnuqoSX2ypzSV8O0XbMOuhFzb27pdxVpyxlMCL2-Lq3l_0RkEYPv91K3_H_Tz1BDyg4R_VRzit0tFlv7WtwbjaqCxI9S-ApBqSL7p2dX0y_wnvw7dPnUdcfGMBzwkTXy_xvSNAB7A |
link.rule.ids | 230,315,730,783,787,867,888,2109,2228,24330,27936,27937,31732,33279,33757,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELaWRQIuiDflaSQOgDZt4tipc4QVVYF2dw_d1d4sv8IGtWnVtEj8e2acZGkRJ65xLFszE883npkvhLxNrBO55TpCbrqIa2aj3GKxA7h66YwTLMbm5OlJNj7nXy_F5QHJul6YULRvTdmv5ot-VV6F2srVwg66OrHB2fQYXFaaijQb3CA34YON-U6UHk7glMkspCmTITIyAiRqE5pSxGxQ_ljp_s8kL5M--Ds8jXdcUmDu_xfc_LtqcscNje6Ruy1-pB-bfd4nB756QG5N2wz5Q-IvytriPROd-LK-QnYLXZc1fXcxeU9bEtA5PfvTdFQd0UljCMv1LzoqQ5dLfURnXQU6PW3qXqiuHD3dbsBE_SNyPvo8Ox5H7a8UIssTuYkS5wO1Ho89RJ5ZUViPTF3DVDsruDGSadBTHBvw53B6u0xyzocO0YIBzOHSx-SwWlb-KaEZSNwmwsk4N7zwHibnxgDQkC52rGA98qGTplo1jBkKIw0UvULRqyB6FUTfI59Q3tcvItl1eLBcf1etypXkGtYZ4qZSLlKvk6LwBXOGmaIQ2vXIm05baoFCnmOd8HJbK0z7Coi3M94jTxrtXS-FPzvlOYcRuafXvb3sj4A9BgLuzv6e_f_U1-T2eDadqMmXk2_PyR0GUKm52HlBDjfrrX8JUGdjXgW7_g3j9_6G |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSBMvE-PajYuReAC0NIljp87jGFQD2q0P27Q3y1eWqU2rpkXi33PsJKNFPPEax7J1zonPZ5_PXxB6l2rDCk1l5LXpIiqJjgrtyQ6Q6rlRhpHEX04en-Wnl_TbNbtuWZV1S6ustCr71XTWr8qbwK1czHTc8cTiyfgEUlaWsSyPF8bF99ED-GiTfGOnHlbhjPA8lCrTgVdlBFjUFjU5S0hc3i5k_2dalGkfcp5fkTfSUlDv_xfk_Js5uZGKho_QXosh8XEz1310z1aP0e64rZI_QfaqrLU_a8IjW9Y3XuFC1mWN31-NPuBWCHSKJ38uHlVHeNQEw3z5Cw_LcNOlPsIXHQsdnzfcFywrg8_XKwhT-xRdDr9cnJxG7e8UIk1TvopSY4O8Hk0s7D5z57T1al2DTBrNqFKcSPBVkijI6bCCm5xTSgfGIwYFuMNkz9BONa_sC4RzsLhOmeFJoaizFjoXSgHY4CYxxJEe-thZUywa1Qzhdxve9MKbXgTTi2D6Hvrk7X33ohe8Dg_myx-idbvgVMI4Az-pjLLMytQ564hRRDnHpOmht523xMwbeeq5wvN1LXzpl8GeO6c99Lzx3t1Q_oentKDQwrf8ujWX7RaIySDC3cXgwf93fYN2J5-HYvT17PshekgALTVnOy_Rzmq5tq8A7azU6xDWvwGFi_-Z |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Visceral+Leishmaniasis+%28VL%29+Clinical+Presentation%2C+Laboratory+Findings%2C+Treatment+Options+and+Outcome&rft.jtitle=Iranian+journal+of+parasitology&rft.au=Khodabandeh%2C+Mahmoud&rft.au=Moradian%2C+Elham&rft.au=Sarvari%2C+Maedeh&rft.au=Khiabani%2C+Mahsa+Soti&rft.date=2024-01-01&rft.issn=1735-7020&rft.volume=19&rft.issue=1&rft.spage=28&rft.epage=37&rft_id=info:doi/10.18502%2Fijpa.v19i1.15190&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1735-7020&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1735-7020&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1735-7020&client=summon |